Abstract
Understanding the in vivo behavior of nanomedicines is critical for optimizing their therapeutic efficacy and facilitating personalized treatment strategies. In the quest to develop positron emission tomography (PET) methodology for liposome biodistribution studies, we systematically compared three liposome radiolabeling strategies - remote loading of 64Cu into liposomes containing the hydrophilic chelator NOTA, membrane labeling using ATSM, and surface labeling with DSPE-NODAGA (phospholipid DSPE conjugated with chelator NODAGA) - to identify an effective method for liposome radiolabeling with 64Cu. Our results demonstrated that DSPE-NODAGA incorporated in PEGylated liposomes allows for achieving 100 % radiochemical yield of 64Cu at room temperature within just 5 min. Stability studies confirmed liposome integrity and minimal transchelation or dissociation in serum over 24 h, highlighting its suitability for in vivo applications. PET/MR imaging in healthy and tumor-bearing mice revealed prolonged circulation of 64Cu-labeled PEGylated liposomes (PL-NODAGA) and significant tumor accumulation, validating DSPE-NODAGA’s potential for real-time tracking of liposome delivery. These findings establish the incorporation of DSPE-NODAGA as a robust and adaptable platform for PET-based monitoring of lipidic nanomedicine.